Atlas Trials

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

Clinical trial NCT03067051 · RECRUITING

Trial details

NCT number
NCT03067051
Sponsor
SpectraCure AB
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Prostate Cancer
Start date
2017-03-21
Primary completion
2027-07-31
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.